Skip to content

Verigene Gram-Positive Blood Culture (Gc-Gp) Nucleic Acid Test

by Nanosphere, Inc.

510(k) K122514

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK122514 Date19 Sep 2012ClearedStatusActive

Recalls

8 recalls · 3 ongoing · FDA

    • Ongoing Z-2533-2024 FDA Class II initiated 20 Jun 2024

    Potential for defective test cartridges which may result in false positive results for the Staphylococcus lugdunensis and Enterococcus faecium targets.

    • Ongoing Z-0500-2024 FDA Class II initiated 7 Nov 2023

    Potentially defective utility trays in the reagent kits.

    • Ongoing Z-2007-2021 FDA Class II initiated 30 Oct 2020 on shared 510(k) K122514

    Potential for a false-negative result.

    • Terminated Z-2775-2020 FDA Class II initiated 15 Jun 2020

    An instrument failure mode that may result in a Blood Culture Gram Positive (BC-GP) or Gram Negative (BC-GN) false negative call.

    • Terminated Z-0822-2019 FDA Class III initiated 26 Dec 2018

    On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label.

    • Terminated Z-0445-2019 FDA Class II initiated 14 Sep 2018

    Potential to lead to a false negative results.

    • Terminated Z-2683-2014 FDA Class II initiated 10 Oct 2013

    Nanosphere has received several reports relating to an increased rate of Processing Errors during procedures performed on the Processor SP caused by Tips in Tip Holder Assemblies for the following products and lots of Extraction Trays.

    • Terminated Z-2735-2014 FDA Class II initiated 17 Jun 2013

    There is a specific Extraction Tray lot containing Tips that may slightly increase the occurrence of Process SP Processing Error when used due to the Processor SP experiencing difficulty releasing the Tip to the final location in the Tip Assembly. The difficult releasing the Tip can result in a Processing Error and occasionally the Tip to be dropped into the Processor SP.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
PAM
Device Class
Class II
Regulation
21 CFR Part 866.3365
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Other devices from Nanosphere, Inc.

See all devices from Nanosphere, Inc. →